Fig. 3From: Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world studyKaplan–Meier analysis of overall and progression free survival. A PFS and B OS for all patients. HR Hazard ratio; RT Radiotherapy; PD1 Monoclonal antibody against programmed cell death; TACE Transcatheter arterial chemoembolization; OS Overall survival; PFS Progression-free survivalBack to article page